Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovský P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E. Pittock SJ, et al. Among authors: bhakta b. Cerebrovasc Dis. 2003;15(4):289-300. doi: 10.1159/000069495. Cerebrovasc Dis. 2003. PMID: 12686794 Clinical Trial.
Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
Hyman N, Barnes M, Bhakta B, Cozens A, Bakheit M, Kreczy-Kleedorfer B, Poewe W, Wissel J, Bain P, Glickman S, Sayer A, Richardson A, Dott C. Hyman N, et al. Among authors: bhakta b. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):707-12. doi: 10.1136/jnnp.68.6.707. J Neurol Neurosurg Psychiatry. 2000. PMID: 10811692 Free PMC article. Clinical Trial.
Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
Preston N, Clarke M, Bhakta B. Preston N, et al. Among authors: bhakta b. J Rehabil Med. 2011 Nov;43(11):1010-5. doi: 10.2340/16501977-0893. J Rehabil Med. 2011. PMID: 22031347 Free article.
Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
Ford GA, Bhakta BB, Cozens A, Hartley S, Holloway I, Meads D, Pearn J, Ruddock S, Sackley CM, Saloniki EC, Santorelli G, Walker MF, Farrin AJ. Ford GA, et al. Among authors: bhakta bb. Lancet Neurol. 2019 Jun;18(6):530-538. doi: 10.1016/S1474-4422(19)30147-4. Lancet Neurol. 2019. PMID: 31122493 Free PMC article. Clinical Trial.
Intrathecal phenol: an old treatment revisited.
Pinder C, Bhakta B, Kodavali K. Pinder C, et al. Among authors: bhakta b. Disabil Rehabil. 2008;30(5):381-6. doi: 10.1080/09638280701353442. Disabil Rehabil. 2008. PMID: 17852295
DVT and pulmonary embolism after acute infection.
Neumann V, O'Connor RJ, Bhakta BB, Tennant A. Neumann V, et al. Among authors: bhakta bb. Lancet. 2006 Jul 15;368(9531):201; author reply 201. doi: 10.1016/S0140-6736(06)69036-3. Lancet. 2006. PMID: 16844486 No abstract available.
87 results